Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy

Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis

(2014) C. Ryan et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Efficacy and safety of etanercept in chronic immune-mediated disease

(2014) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety

(2014) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Potential use of TNF-α inhibitors in systemic sclerosis

(2014) Giuseppe Murdaca et al.   Immunotherapy

TNF-α Gene Polymorphisms: Association with Disease Susceptibility and Response to Anti-TNF-α Treatment in Psoriatic Arthritis

(2014) Giuseppe Murdaca et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis

(2013) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Selective TNF-α inhibitor-induced injection site reactions

(2013) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Effects of TNF-α inhibitors upon the mechanisms of action of VEGF

(2013) Giuseppe Murdaca et al.   Immunotherapy

Free radicals and endothelial dysfunction: Potential positive effects of TNF-α inhibitors

(2013) Giuseppe Murdaca et al.   REDOX REPORT

The Role of Fcγ Receptor Polymorphisms in the Response to Anti–Tumor Necrosis Factor Therapy in Psoriasis

(2013) Marc Julià et al.   JAMA Dermatology

Endothelial dysfunction in rheumatic autoimmune diseases

(2012) Giuseppe Murdaca et al.   ATHEROSCLEROSIS

Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis

(2012) María José Morales-Lara et al.   JOINT BONE SPINE

Determination of Lymphotoxin-Alpha Levels in Patients with Psoriatic Arthritis Undergoing Etanercept Treatment

(2012) Giuseppe Murdaca et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

-174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis

(2012) Ivan Jančić et al.   RHEUMATOLOGY INTERNATIONAL

Association of TNF-alpha polymorphism (-308 A/G) with high activity of rheumatoid arthritis and therapy response to etanercept

(2012) Sonja Stojanovic et al.   Srpski Arhiv za Celokupno Lekarstvo

Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists

(2012) Gulen Hatemi et al.   ARTHRITIS RESEARCH & THERAPY

Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response

(2011) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Emerging biological drugs: A new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

(2011) Giuseppe Murdaca et al.   AUTOIMMUNITY REVIEWS

Update upon efficacy and safety of TNF-α inhibitors

(2011) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases

(2011) Giuseppe Murdaca et al.   Internal and Emergency Medicine

TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis

(2011) Trilokraj Tejasvi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Anti-Tumor Necrosis Factor-α Treatment with Infliximab for Disseminated Granuloma Annulare

(2010) Giuseppe Murdaca et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment

(2010) R. J. L. Tan et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF B signalling pathways

(2010) C. Potter et al.   ANNALS OF THE RHEUMATIC DISEASES

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1

(2010) Amy Strange et al.   NATURE GENETICS

Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease

(2009) Eugene Y Chiang et al.   NATURE MEDICINE

Vascular effects of biologic agents in RA and spondyloarthropathies

(2009) Zoltán Szekanecz et al.   Nature Reviews Rheumatology

Serum vascular endothelial growth factor and sublingual immunotherapy

(2008) G. Ciprandi et al.   ALLERGY

Influence of variants of Fc  receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor   therapy in rheumatoid arthritis

(2008) J D Canete et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor

(2008) Hubert Marotte et al.   ARTHRITIS AND RHEUMATISM

Traditional and non traditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus: Role of vascular endothelial growth factor (VEGATS Study)

(2008) Barbara Maria Colombo et al.   AUTOIMMUNITY REVIEWS

Specificity and affinity of human Fc  receptors and their polymorphic variants for human IgG subclasses

(2008) P. Bruhns et al.   BLOOD

Performance of two commercial blood IFN-γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-α treatment

(2008) M. Bocchino et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis

(2008) Francesca Fantuzzi et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus

(2008) Giorgio Ciprandi et al.   HUMAN IMMUNOLOGY

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

(2008) James R. Maxwell et al.   HUMAN MOLECULAR GENETICS